/PRNewswire/ - Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned.
/PRNewswire/ - Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the Company.
/PRNewswire/ - Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the Company.
Chemistree Sells Desert Hot Springs Development Property prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
VANCOUVER, BC, Feb. 8, 2021 /PRNewswire/ - Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (OTCQB: CHMJF) (the Company or Chemistree ) is pleased to inform shareholders that Chemistree investee ImmunoFlex™ has today announced that it is receiving advisory services and conditional research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). ImmunoFlex is now recruiting patients into a Phase 4 clinical trial designed to optimize the impact of FLEX 20
TM on the immune system. The funding from NRC IRAP will support a project focused on analyzing immune system data collected from this clinical trial, said ImmunoFlex CEO Chris Wagner. We are grateful for their support.